-
CICON24 Day 1 Recap: Groundbreaking Research and Collaboration Driving the Future of Cancer Immunotherapy
NATIONAL HARBOR — CICON24 officially kicked off today at the Gaylord National Resort and Convention Center in… -
Key Discoveries from the AMADEUS Clinical Trial on Cancer Treatment
The Cancer Research Institute (CRI) is excited to share the findings from the AMADEUS clinical trial, which… -
Can Table Salt Supercharge Your Immune System to Fight Cancer?
The Cancer Research Institute (CRI) is excited to share the latest study from CRI Lloyd J. Old… -
Tecelra® Receives FDA Approval: A New Milestone in Cancer Treatment
On August 2, 2024, the U.S Food and Drug Administration (FDA) approved Tecelra® (afamitresgene autoleucel), a gene… -
How Focused Ultrasound and Immunotherapy Could Transform Cancer Treatment
Recent advancements in cancer treatment are reshaping patient care in multiple ways. Focused ultrasound and cancer immunotherapy… -
How Proteasomes are Changing the Face of Cancer Immunotherapy
Cancer immunotherapy is revolutionizing treatment by harnessing the power of the body’s own immune system to recognize,… -
Immune Cell Triads Unveil a Critical Role in Fighting Solid Tumors
The Cancer Research Institute (CRI) is excited to share the latest study from CRI Lloyd J. Old… -
FDA approves EPKINLY® for relapsed or refractory follicular lymphoma
June 26, 2024, marked a milestone for patients suffering from follicular lymphoma. The FDA approved Genmab’s epcoritamab-bysp… -
What’s in Your Glass? Weighing the Health Risks of Alcohol Consumption
“Just one for the road.” We’ve all heard or said this at a party. Alcohol is a…
